2 completed, 2 terminated, 2 unknown. 6 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 6 | Completed 2, Terminated 2, Unknown 2 |
| Phase 2 | 1 | Unknown 1 |
Follow Microspheres: new trials by email Literature Review of Microspheres trials Research Report on Microspheres
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Transarterial Embolization Alone Versus Drug-Eluting Beads Chemoembolization for Hepatocellular Carcinoma DEB-TACE, TAE - Carcinoma, Hepatocellular | Phase 3 | Unknown | IRCCS Azienda Ospedaliero-Universitaria di Bologna | 154 | 2019-12-04 | 2021-03-19 |
| Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization Holmium-166-poly (L-lactic acid) microspheres - Colorectal Neoplasms, Neoplasm Metastasis | Phase 2 / Phase 3 | Unknown | UMC Utrecht | 25 | 2014-11-01 | 2016-11-09 |
| Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy Octreotide acetate in microspheres - Diabetic Retinopathy | Phase 3 | Terminated | Novartis Pharmaceuticals | 260 | 2005-11-01 | 2012-04-10 |
| Extension Study of the Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy Octreotide acetate in microspheres - Diabetic Retinopathy | Phase 3 | Terminated | Novartis Pharmaceuticals | 105 | 2005-11-01 | 2012-05-01 |
| Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy Octreotide Acetate in Microspheres, Placebo - Diabetic Retinopathy | Phase 3 | Completed | Novartis | 312 | 2000-02-01 | 2011-11-17 |
| Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy Octreotide Acetate in Microspheres 20 mg, Octreotide Acetate in Microspheres, Placebo - Diabetic Retinopathy | Phase 3 | Completed | Novartis | 583 | 1999-11-01 | 2011-11-17 |
Diabetic Retinopathy (4) · Carcinoma, Hepatocellular (1) · Colorectal Neoplasms (1) · Digestive System Neoplasms (1) · Liver Diseases (1) · Neoplasm Metastasis (1)
Novartis (2) · Novartis Pharmaceuticals (2) · IRCCS Azienda Ospedaliero-Universitaria di Bologna (1) · UMC Utrecht (1)
United States (2) · Italy (1) · Netherlands (1)
Max A Viergever, Prof. dr. ir. (1) · Rita Golfieri, Professor (1)